Quarterly report (Form 10-Q)
Quest Diagnostics 10-Q for Quarter ended Sep 30, 2026
Filing excerpt
DIS volume increased by 14.5% compared to the prior year period (principally driven by organic growth of 14.4%) of which 9.5% was due to both our new relationships with Corewell Health to provide Collaborative Lab Solutions and increasing our laboratory testing at dialysis clinics owned by Fresenius Medical Care in the United States.